Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

An after view of the indoor stadium at Patliputra Sports Complex.  The teams are working to set up a 100-bed COVID-19 treatment facility in the indoor stadium of Patliputra Sports Complex, Patna with the purpose of treating cases of COVID-19.  The intervention aims to reduce the morbidity and mortality associated with the COVID-19 outbreak in Patna.  This facility will help in decongesting the government hospitals to allow more effective resource management of severe cases of COVID-19. Photograph by MSF
Press release
Press release |
23 June 2020
COVID-19

Ahead of Gavi Board meeting, MSF calls on Gavi to revise its global mechanism and demand pharma sell all COVID-19 vaccines at cost

5 min
In June and July 2016 MSF has been conducting vaccination campaigns in several refugee camps and settlements in Greece, targeting more than 4,600 children under fifteen years of age. This campaign aims at protecting refugee children with 10 antigens and preventing diseases such as pneumonia, which is the leading cause of childhood death. MSF calls on Pfizer and GSK to drop the price of the pneumonia vaccine (PCV) for governments and humanitarian organizations in emergency contexts. Photograph by Sophia Apostolia
Press release
Press release |
04 June 2020
Vaccines
Global

MSF responds to news that Gavi will release funds from pneumonia vaccine ‘Advance Market Commitment’ to first new product from a developing country manufacturer

5 min
COVID-19 intervention in Brussels, Belgium Photo by Albert Massias
Press release
Press release |
02 June 2020
COVID-19

MSF: Any future COVID-19 vaccines must be sold at cost and accessible to all

5 min
Press release
Press release |
29 May 2020
COVID-19

MSF welcomes WHO Solidarity Call to Action to share COVID-19 technology and intellectual property

Hanif is 25 years old, lives in Mumbai, and is one of only a handful of extensively drug-resistant TB (XDR-TB) patients in India lucky enough to be able to have acesss to the new drugs. After having failed treatment for the fourth time, Hanif was referred to the clinic of Medecins Sans Frontieres (MSF) / Doctors Without Borders, an international medical humanitarian organisation who since 2006 provides free diagnosis, treatment and support to patients with drug-resistant TB in Mumbai. Photograph by Atul Loke
Press release
Press release |
01 May 2020
Intellectual property and trade
United States of AmericaIndia

MSF responds to USTR 2020 Special 301 Report

4 min
Press release |
16 April 2020
COVID-19
United Kingdom

International organisations call on UK government to prevent Big Pharma profiteering from COVID-19

MSF Actions On Covid-19 Pandemic
Press release
Press release |
10 April 2020
COVID-19

MSF response on COVID-19 drugs pricing study by Andrew Hill et al.

MSF started activities linked to COVID 19 in France, focusing on vulnerable people living in the streets, such as migrants. On March 24th, 700 people were evacuated from a camp in Aubervilliers near Paris, where they were living in precarious conditions. They were dispatched on various emergency shelters located in Paris and Ile de France. MSF teams are deployed in some of these shelters to evaluate their health and identify potential COVID 19 cases.
Press release
Press release |
30 March 2020
COVID-19
Europe

MSF steps up COVID-19 response in Europe

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury